We demonstrated that treatment of OVA-induced rats with GEB has the potential to alleviate asthma symptoms, such as airway inflammation and mucus hypersecretion, by reducing type 2 cytokines, IgE, and inflammatory cells. The gene discussed is IGHE; the disease is asthma.